From: Characteristics of lymphocyte subsets and cytokine profiles of patients with COVID-19
Characteristic | Total (n = 53) | Severe group (n = 37) | Critical group (n = 16) | Z value | P value |
---|---|---|---|---|---|
Lymphocyte classification | Â | Â | Â | Â | Â |
Lymphocyte, median (IQR), × 106/L | 597.00 (420.50–870.00) | 695.00 (423.00–902.00) | 535.00 (367.50–704.75) | − 1.395 | 0.163 |
CD3+, median (IQR), × 106/L | 399.00 (196.50–547.50) | 430.00 (211.00–590.00) | 327.00 (175.25–476.75) | − 1.085 | 0.278 |
CD4+, median (IQR), × 106/L | 243.00 (118.00–341.00) | 261.00 (131.50–377.00) | 211.00 (86.50–294.75) | − 1.279 | 0.201 |
CD8+, median (IQR), × 106/L | 140.00 (87.50–209.00) | 157.00 (89.00–227.50) | 117.50 (84.75–160.25) | − 1.143 | 0.253 |
CD19+, median (IQR), × 106/L | 103.00 (73.50–144.50) | 103.00 (80.00–146.00) | 99.00 (46.00–131.00) | − 1.163 | 0.245 |
NK, median (IQR), × 106/L | 103.00 (60.50–166.00) | 109.00 (67.50–168.50) | 87.00 (49.50–130.00) | − 1.424 | 0.154 |
CD3+, median (IQR),% | 61.33 (50.67–68.25) | 61.33 (50.96–67.90) | 61.37 (49.94–70.59) | 0.446 | 0.656 |
CD4+, median (IQR),% | 35.84 (28.26–42.69) | 36.04 (29.87–42.89) | 30.14 (26.93–40.06) | − 0.911 | 0.363 |
CD8+, median (IQR),% | 21.98 (16.61–28.62) | 21.10 (16.61–27.49) | 22.77 (16.09–36.27) | 0.581 | 0.561 |
CD19+, median (IQR),% | 17.92 (13.04–22.91) | 17.73 (14.38–22.93) | 18.87 (11.86–22.82) | − 0.271 | 0.786 |
NK, median (IQR),% | 19.28 (10.66–26.77) | 19.18 (13.41–27.32) | 19.39 (9.23–26.18) | − 0.542 | 0.587 |
CD4+/CD8+, median (IQR) | 1.53 (1.09–2.33) | 1.71 (1.12–2.08) | 1.23 (0.83–2.55) | 0.794 | 0.416 |
Cytokine profiles | Â | Â | Â | Â | Â |
IL-4, median (IQR), pg/mL | 1.73 (1.33–2.45) | 1.68 (1.32–2.45) | 1.98 (1.32–2.50) | 0.523 | 0.607 |
IL-6, median (IQR), pg/mL | 16.39 (4.53–49.63) | 11.61 (2.48–46.45) | 21.89 (7.20–85.51) | 1.437 | 0.151 |
IL-10, median (IQR), pg/mL | 3.76 (2.85–5.17) | 3.44 (2.70–5.17) | 4.79 (3.23–6.25) | 1.744 | 0.081 |
IL-17, median (IQR), pg/mL | 1.19 (1.04–1.40) | 1.18 (1.04–1.36) | 1.20 (1.04–1.47) | − 0.058 | 0.954 |
TNF-α, median (IQR), pg/mL | 3.52 (2.14–5.42) | 3.54 (1.92–5.59) | 2.93 (2.19–5.25) | − 0.203 | 0.839 |
IFN-γ, median (IQR), pg/mL | 5.18 (2.27–8.72) | 5.42 (1.95–9.81) | 4.08 (2.35–7.44) | − 0.668 | 0.504 |